Edition:
India

Keryx Biopharmaceuticals Inc (KERX.OQ)

KERX.OQ on NASDAQ Stock Exchange Capital Market

4.76USD
20 Apr 2018
Change (% chg)

$-0.08 (-1.65%)
Prev Close
$4.84
Open
$4.85
Day's High
$4.89
Day's Low
$4.76
Volume
221,087
Avg. Vol
351,960
52-wk High
$8.37
52-wk Low
$3.92

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 18.68 -1.192
Sep '17 15.00 -0.197
Jun '17 15.14 -0.768
Mar '17 11.82 -0.215
FY 2016 Dec '16 9.53 -0.319
Sep '16 6.34 -0.394
Jun '16 9.29 -0.422
Mar '16 6.82 -0.388
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 5 25.24 26.54 23.00 29.89
Quarter Ending Sep-18 5 28.90 30.70 27.00 33.42
Year Ending Dec-18 7 106.87 114.31 94.50 124.92
Year Ending Dec-19 7 171.55 239.70 128.70 196.83
Earnings (per share)
Quarter Ending Jun-18 8 -0.16 -0.13 -0.22 -0.05
Quarter Ending Sep-18 8 -0.13 -0.10 -0.19 -0.02
Year Ending Dec-18 7 -0.59 -0.47 -0.81 -0.25
Year Ending Dec-19 7 -0.20 -0.03 -0.32 0.10
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 133.79 65.94 44.94
EPS (TTM) % -28.41 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Keryx Biopharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 67.12%
# of Holders: 180
Total Shares Held: 79,992,650
3 Mo. Net Change: 256,308
# New Positions: 3
# Closed Positions: 3
# Increased Positions: 10
# Reduced Positions: 11
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.